hemophilia gene therapy
Analysts predict that BioMarin’s hemophilia A gene therapy may succeed in Europe
SG Tylor
According to a report published by SVB Securities analysts Joseph Schwartz and Joori Park, Ph.D., Roctavian may have a “significant ...
